Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
2.020
-0.150 (-6.91%)
At close: May 15, 2026, 4:00 PM EDT
2.110
+0.090 (4.46%)
After-hours: May 15, 2026, 7:57 PM EDT
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of $181.81 million as of May 15, 2026. Its market cap has increased by 1.04% in one year.
Market Cap
181.81M
Enterprise Value
168.11M
1-Year Change
1.04%
Ranking
Category
Stock Price
$2.02
Market Cap Chart
Since May 17, 2021, Innate Pharma's market cap has decreased from $313.62M to $181.81M, a decrease of -42.03%. That is a compound annual growth rate of -10.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 189.23M | 26.65% |
| Dec 31, 2025 | 149.41M | 0.18% |
| Dec 31, 2024 | 149.14M | -33.91% |
| Dec 29, 2023 | 225.64M | -24.56% |
| Dec 30, 2022 | 299.12M | -17.53% |
| Dec 31, 2021 | 362.71M | 15.65% |
| May 17, 2021 | 313.62M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Molecular Partners AG | 143.91M |
| Aardvark Therapeutics | 143.77M |
| Genelux | 141.66M |
| Spero Therapeutics | 141.28M |
| Alps Group | 139.79M |
| Connect Biopharma Holdings | 138.48M |
| OnKure Therapeutics | 137.34M |
| NeOnc Technologies Holdings | 136.53M |